Atypical antipsychotic

• Atypical antipsychotics are a class of medications primarily used in the treatment of schizophrenia and other psychotic disorders.
• They are called "atypical" to distinguish them from the older, first-generation antipsychotics, which are now referred to as "typical" antipsychotics.
• They are also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs).
• Atypical antipsychotics are known for their improved efficacy and reduced risk of certain side effects compared to typical antipsychotics.

Mechanisms of Action

The exact mechanisms of action of atypical antipsychotics are not fully understood, but they are thought to involve interactions with various neurotransmitter systems in the brain, including dopamine, serotonin, and others.

Some common mechanisms of action include:

1. Dopamine D2 Receptor Antagonism:

• Atypical antipsychotics block dopamine receptors, particularly the D2 receptors, which helps to reduce the hyperactivity of dopamine pathways in the brain associated with psychotic symptoms.

2. Serotonin 5-HT2A Receptor Antagonism:

• Atypical antipsychotics also have antagonistic effects on serotonin 5-HT2A receptors.
• This interaction is believed to contribute to their efficacy in treating both positive and negative symptoms of schizophrenia.

3. Modulation of Other Neurotransmitter Systems:

• Atypical antipsychotics may also interact with other neurotransmitter systems, such as norepinephrine and glutamate, which are involved in regulating mood, cognition, and psychosis.

Medical Applications

• Atypical antipsychotics are primarily used in the treatment of psychotic disorders, such as schizophrenia, but they may also have other therapeutic applications.

Some common medical applications of atypical antipsychotics include:

1. Schizophrenia:

• Atypical antipsychotics are the primary treatment for schizophrenia. They help alleviate positive symptoms (such as hallucinations and delusions) and negative symptoms (such as social withdrawal and lack of motivation) associated with the condition.

2. Bipolar Disorder:

• Atypical antipsychotics may be used as part of a comprehensive treatment plan for bipolar disorder, helping to manage manic or mixed episodes.

3. Major Depressive Disorder (Adjunctive Treatment):

• In some cases, atypical antipsychotics may be used as an adjunctive treatment in major depressive disorder, particularly when other medications have been ineffective.

4. Autism Spectrum Disorders:

• Atypical antipsychotics may be prescribed to manage disruptive behaviors, aggression, and irritability associated with autism spectrum disorders.

5. Tourette Syndrome:

• Some atypical antipsychotics have been found to be effective in reducing the frequency and severity of tics in individuals with Tourette syndrome.

Common Atypical Antipsychotics

• There are several atypical antipsychotic medications available, each with its own characteristics and indications.

Some commonly used atypical antipsychotics include: 1. Aripiprazole 2. Clozapine 3. Olanzapine 4. Quetiapine 5. Risperidone 6. Ziprasidone 7. Paliperidone 8. Lurasidone

• These medications may differ in their specific receptor affinities, dosing regimens, and potential side effects. The choice of medication will depend on factors such as the patient's condition, symptom severity, and individual response to treatment.

Adverse Effects

• While atypical antipsychotics are generally associated with a lower risk of movement disorders compared to typical antipsychotics, they can still produce side effects.

Common adverse effects of atypical antipsychotics may include:

• Weight gain and metabolic changes
• Sedation or drowsiness
• Extrapyramidal symptoms (such as parkinsonism, dystonia, and akathisia)
• Hyperprolactinemia (elevated levels of the hormone prolactin)
• Cardiac effects (e.g., QT prolongation)
• Metabolic syndrome (including increased blood sugar, cholesterol, and blood pressure)

Contraindications

• Atypical antipsychotics may be contraindicated in certain situations due to an increased risk of adverse effects or interactions with other medications.

Contraindications may include:

• Known hypersensitivity or allergy to the specific medication
• Severe cardiovascular disease
• History of neuroleptic malignant syndrome (NMS) with previous antipsychotic use
• Severe liver or kidney disease
• Pregnancy or breastfeeding (potential risks to the fetus or newborn)
• The decision to use atypical antipsychotics should be individualized based on the patient's specific condition, risks, and benefits, and under the guidance of a healthcare professional.

Drug Interactions

• Atypical antipsychotics can interact with other medications, potentially affecting their effectiveness or increasing the risk of adverse effects. It's crucial to inform healthcare professionals about all medications, including prescription, over-the-counter, and herbal supplements, that you are taking.

Some common drug interactions with atypical antipsychotics include:

1. Central Nervous System Depressants:

• Combining atypical antipsychotics with other central nervous system depressants, such as benzodiazepines, sedatives, or alcohol, may increase the sedative effects and impair cognitive function. Caution should be exercised when using these medications together, and dosage adjustments may be necessary.

2. Anticholinergic Medications:

• The combination of atypical antipsychotics with anticholinergic medications, such as some antihistamines or medications for Parkinson's disease, may increase the risk of anticholinergic side effects like dry mouth, constipation, urinary retention, and blurred vision. Close monitoring is recommended, and alternative medications may be considered.

3. QT-Prolonging Medications:

• Some atypical antipsychotics, particularly ziprasidone and quetiapine, may prolong the QT interval on an electrocardiogram. Concurrent use of other medications known to prolong the QT interval, such as certain antibiotics (e.g., macrolides), antiarrhythmics, or antifungals, may increase the risk of potentially life-threatening cardiac arrhythmias. Careful monitoring of cardiac function and consideration of alternative medications are important in such cases.

4. CYP450 Enzyme Inhibitors or Inducers:

• Atypical antipsychotics are metabolized by various cytochrome P450 enzymes in the liver. Drugs that inhibit or induce these enzymes can influence the metabolism and plasma levels of atypical antipsychotics. For example, inhibitors of CYP3A4, such as fluconazole or certain HIV protease inhibitors, may increase the plasma concentrations of some atypical antipsychotics. Conversely, inducers of CYP3A4, like rifampin or carbamazepine, may decrease the plasma levels and effectiveness of atypical antipsychotics. Dose adjustments or alternative medications may be necessary in these cases.

5. Medications that Increase the Risk of Metabolic Syndrome:

• Some atypical antipsychotics are associated with an increased risk of metabolic syndrome, characterized by weight gain, dyslipidemia, and insulin resistance. Concurrent use of medications known to exacerbate these metabolic effects, such as certain antidepressants (e.g., mirtazapine), antiepileptic drugs (e.g., valproate), or certain antihypertensives, may further increase the risk. Regular monitoring of metabolic parameters is essential, and consideration of alternative medications with a lower metabolic burden may be warranted.

• It's important to remember that this is not an exhaustive list of all possible drug interactions. Always consult with a healthcare professional or pharmacist to review potential interactions based on your specific medications and medical history.

See Also

• Schizophrenia
• Psychotic Disorders
• Dopamine
• Serotonin
• Neurotransmitters

Atypical antipsychotic Resources
Latest articles Most recent articles Ongoing trials	Wikipedia